BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 17161069)

  • 21. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
    Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
    Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.
    Hordijk-Trion M; Lenzen M; Wijns W; de Jaegere P; Simoons ML; Scholte op Reimer WJ; Bertrand ME; Mercado N; Boersma E;
    Eur Heart J; 2006 Mar; 27(6):671-8. PubMed ID: 16423872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?
    Mehta RH; Lopes RD; Ballotta A; Frigiola A; Sketch MH; Bossone E; Bates ER
    Am Heart J; 2010 Jan; 159(1):141-7. PubMed ID: 20102880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel.
    Gruberg L; Milo S; Ben Tzvi M; Lotan C; Merin G; Braun S; Mohr R; Tzivoni D; Bitran D; Beyar R;
    Isr Med Assoc J; 2003 Aug; 5(8):539-42. PubMed ID: 12929288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for impaired health status differ in women and men treated with percutaneous coronary intervention in the drug-eluting stent era.
    Pedersen SS; Ong AT; Lemos PA; Erdman RA; Serruys PW; van Domburg RT
    J Psychosom Res; 2006 Jul; 61(1):11-7. PubMed ID: 16813840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
    Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
    Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization.
    Buszman PE; Kiesz SR; Bochenek A; Peszek-Przybyla E; Szkrobka I; Debinski M; Bialkowska B; Dudek D; Gruszka A; Zurakowski A; Milewski K; Wilczynski M; Rzeszutko L; Buszman P; Szymszal J; Martin JL; Tendera M
    J Am Coll Cardiol; 2008 Feb; 51(5):538-45. PubMed ID: 18237682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.
    Bair TL; Muhlestein JB; May HT; Meredith KG; Horne BD; Pearson RR; Li Q; Jensen KR; Anderson JL; Lappé DL
    Circulation; 2007 Sep; 116(11 Suppl):I226-31. PubMed ID: 17846308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study.
    van Domburg RT; Takkenberg JJ; Noordzij LJ; Saia F; van Herwerden LA; Serruys PW; Bogers AJ
    Ann Thorac Surg; 2005 May; 79(5):1563-9. PubMed ID: 15854934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological outcome after percutaneous coronary intervention or coronary artery bypass grafting: results from the Stent or Surgery (SoS) Trial.
    Währborg P; Booth JE; Clayton T; Nugara F; Pepper J; Weintraub WS; Sigwart U; Stables RH;
    Circulation; 2004 Nov; 110(22):3411-7. PubMed ID: 15557380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health related quality of life after percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with acute coronary syndromes without ST-segment elevation. 12-month follow up.
    Szygula-Jurkiewicz B; Zembala M; Wilczek K; Wojnicz R; Polonski L
    Eur J Cardiothorac Surg; 2005 May; 27(5):882-6. PubMed ID: 15848330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial.
    Favarato ME; Hueb W; Boden WE; Lopes N; Nogueira CR; Takiuti M; Góis AF; Borges JC; Favarato D; Aldrighi JM; Oliveira SA; Ramires JA
    Int J Cardiol; 2007 Apr; 116(3):364-70. PubMed ID: 16876891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
    Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HRQoL after coronary artery bypass grafting and percutaneous coronary intervention for stable angina.
    Loponen P; Luther M; Korpilahti K; Wistbacka JO; Huhtala H; Laurikka J; Tarkka MR
    Scand Cardiovasc J; 2009 Apr; 43(2):94-9. PubMed ID: 18819033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.